AMSTERDAM (AP) – The European Union’s drug regulator said Monday it has begun evaluating a request by Pfizer Inc. and BioNTech to extend approval of their coronavirus vaccine to include children ranging in age from 12 to 15.

The European Medicines Agency’s human medicines committee will carry out an accelerated …
Source: The Washington Times